ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.00
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      63,705.17
      0.46%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Daxor Corporation (DXR)

      7. Daxor Corporation (DXR) News

      DXR Daxor Corporation

      9.65
      0.00 (0.00%)
      Apr 26 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Daxor Corporation DXR NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 9.65 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      9.80 9.65 9.80 9.65 9.65
      more quote information »

      Recent News

      Date Time Source Heading
      4/16/202408:00GLOBENew Studies Prove the Clinical Benefits of Daxor’s Blood..
      4/15/202408:00GLOBEDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR..
      4/10/202408:00GLOBEDaxor Corporation Announces New Hospital Account at Leading..
      4/01/202408:00GLOBEDaxor Corporation to Exhibit at the American College of..
      3/25/202408:00GLOBEDaxor Corporation Acquires Volumex® and Megatope® From Its..
      3/22/202408:00GLOBEDaxor Corporation to Hold Investor Call Discussing Fiscal..
      3/18/202414:18GLOBEDaxor Corporation CEO and President Michael Feldschuh..
      3/11/202408:00GLOBEDaxor Announces Sales to Three New Hospitals Furthering..
      3/08/202413:49EDGAR2Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of..
      3/08/202408:00GLOBEMulti-Center Study Presented by Duke at Heart Failure..
      3/06/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/29/202417:28EDGAR2Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of..
      2/29/202416:15EDGAR2Form NT-NCSR - Notice under Exchange Act Rule 12b-25 of..
      2/26/202408:00GLOBEDaxor Corporation to Exhibit at the Technology and Heart..
      2/12/202408:00GLOBEDaxor Corporation Starts 2024 with Ongoing Growth in New..
      2/07/202408:00GLOBEDaxor Corporation Closes Q4 2023 with Growth in New Sales to..
      1/29/202408:00GLOBEDaxor Corporation to Exhibit at the Society of Nuclear..
      1/16/202408:00GLOBEDaxor Corporation to Exhibit at the Society for Critical..
      1/09/202408:00GLOBEDAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME..
      1/02/202408:52EDGAR2Form 8-K - Current report
      1/02/202408:30GLOBEDaxor Corporation Submits Dual 510(k)/CLIA-waiver..
      12/06/202315:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/01/202321:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/01/202320:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/27/202306:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/24/202313:53EDGAR2Form NPORT-P - Monthly Portfolio Investments Report on Form..
      11/24/202311:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/13/202308:00GLOBENew Randomized Controlled Trial Demonstrates the Efficacy of..
      11/13/202306:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/09/202308:00GLOBEDaxor Corporation Awarded New Patent for Remote Monitoring..
      11/02/202318:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/27/202317:27EDGAR2Form 8-K - Current report
      10/16/202312:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/13/202308:00GLOBEExpert Panelists Advocate Use of Daxor’s Technology to..
      10/11/202308:00GLOBENew Data from Banner University Medicine Demonstrating..
      10/04/202308:00GLOBEDaxor Corporation Awarded Support from the National..
      9/27/202308:00GLOBEDaxor Corporation to Exhibit at the Heart Failure Society of..
      9/26/202309:14EDGAR2Form 40-17G - Fidelity Bond [Rule 17G-1(g)]
      9/26/202308:00GLOBEDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR..
      9/20/202316:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/11/202312:00GLOBEDaxor Corporation Awarded $305K Grant from the National..
      9/07/202309:15GLOBEDaxor Corporation to Present at the H.C. Wainwright 25th..
      8/28/202316:15GLOBEDaxor Corporation CEO and President Michael Feldschuh..
      8/28/202316:05GLOBEDaxor Corporation Reports a 20.64 Percent Increase in..
      8/28/202316:01EDGAR2Form N-CSRS - Certified Shareholder Report, Semi-Annual
      8/15/202307:14EDGAR2Form N-PX - Annual Report of proxy voting record of..
      8/10/202308:00GLOBEJACC-HF Reports Successful Heart Failure Trial With Daxor..
      7/13/202316:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/13/202316:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/13/202316:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..

      Your Recent History

      NASDAQ
      DXR
      Daxor
      Delayed Upgrade Clock